Prestige BioPharma Limited (KRX:950210)

Prestige BioPharma Revenue

Prestige BioPharma had revenue of 3.34B KRW in the quarter ending March 31, 2025, with 422.99% growth. This brings the company's revenue in the last twelve months to 8.66B, up 776.76% year-over-year. In the fiscal year ending June 30, 2024, Prestige BioPharma had annual revenue of 689.08M with 325.77% growth.

• Revenue (ttm): 8.66B
• Revenue Growth: +776.76%
• P/S Ratio: 22.34
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 193.51B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	689.08M	527.23M	325.77%
Jun 30, 2023	161.84M	-	-
Jun 30, 2022	-	-	-
Jun 30, 2021	-	-	-
Jun 30, 2020	-	-	-